Currently, intravenous tissue plasminogen activator (IV-tPA) combined with endovascular thrombectomy (EVT) is the standard therapeutic scheme for patients with AIS induced by large vessel occlusion (LVO) [82]. This evidence concerns the gene PLAT and androgen insensitivity syndrome.